Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AKBA · against 254 other Healthcare companies of similar size
Ranked #217 of 255 · scores higher than 15% of peers · safety percentile 12
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)18 peers with a safety percentile of 10–19, including AKBA · Click a bar to see the companies
Mainly because of its debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | AKBA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 226 reported | 7.96× | 0.21× | 1% | 33% | |
| BetaLower is better · 242 reported | 0.18 | 0.58 | 85% | 33% | |
| Current ratioHigher is better · 251 reported | 1.43× | 3.32× | 22% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 165M USD | 99 | 50 | |
| 3 | 261M USD | 99 | 97 | |
| 4 | 397M USD | 99 | 37 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 213 | 19.8B INR (≈$238M) | 14 | 37 | |
| 214 | 302M USD | 13 | 17 | |
| 215 | 1.8B HKD (≈$224M) | 13 | 59 | |
| 216 | 1.0B MYR (≈$229M) | 12 | 44 | |
| 217 | 201M USD | 12 | 24 | |
| 218 | 1.9B CNY (≈$270M) | 12 | 17 | |
| 219 | 222M USD | 10 | 31 | |
| 220 | 365M EUR (≈$401M) | 10 | 44 | |
| 221 | 320M USD | 10 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score